Epigenetic targeting of Notch1-driven transcription using the HDACi panobinostat is a potential therapy against T-cell acute lymphoblastic leukemia. Article uri icon

Overview

publication date

  • September 15, 2017

Research

keywords

  • Epigenesis, Genetic
  • Leukemia, T-Cell
  • Panobinostat
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma
  • Receptor, Notch1
  • T-Lymphocytes
  • Transcription, Genetic

Identity

Scopus Document Identifier

  • 85040146562

Digital Object Identifier (DOI)

  • 10.1038/leu.2017.282

PubMed ID

  • 28914259

Additional Document Info

volume

  • 32

issue

  • 1